AKT1 and hepatocellular carcinoma: We previously observed that FLJ10540 not only plays important roles in the oncogenesis of several malignancies, including hepatocellular carcinoma [19], lung cancer [27], and NPC [28], but also enhances the transformation and invasion of cancer cells via AKT activation [19,27].